# Mahesh Parmar

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mahesh-parmar/

## Facts

| Field | Value |
| --- | --- |
| Citations | 59,598 |
| Field | Statistical Methods in Clinical Trials |
| h-index | 105 |
| i10-index | 299 |
| Last Known Institution | MRC Clinical Trials Unit at UCL |
| OpenAlex ID | https://openalex.org/A5014097745 |
| ORCID iD | https://orcid.org/0000-0003-0166-1700 |
| Works | 552 |

## Researcher papers

Showing 12 of 14.

- [A Phase 3 Trial of Bevacizumab in Ovarian Cancer](https://scholariq.org/papers/a-phase-3-trial-of-bevacizumab-in-ovarian-cancer/)
- [Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial](https://scholariq.org/papers/addition-of-docetaxel-zoledronic-acid-or-both-to-first-line-long-term-hormone/)
- [Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy](https://scholariq.org/papers/abiraterone-for-prostate-cancer-not-previously-treated-with-hormone-therapy/)
- [Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial](https://scholariq.org/papers/radiotherapy-to-the-primary-tumour-for-newly-diagnosed-metastatic-prostate/)
- [Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial](https://scholariq.org/papers/paclitaxel-plus-platinum-based-chemotherapy-versus-conventional-platinum-based/)
- [Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial](https://scholariq.org/papers/ovarian-cancer-screening-and-mortality-in-the-uk-collaborative-trial-of-ovarian/)
- [Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial](https://scholariq.org/papers/standard-chemotherapy-with-or-without-bevacizumab-for-women-with-newly-diagnosed/)
- [Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial](https://scholariq.org/papers/timing-of-radiotherapy-after-radical-prostatectomy-radicals-rt-a-randomised/)
- [Adjuvant chemotherapy for resected early-stage non-small cell lung cancer](https://scholariq.org/papers/adjuvant-chemotherapy-for-resected-early-stage-non-small-cell-lung-cancer/)
- [Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis](https://scholariq.org/papers/role-of-radiotherapy-fractionation-in-head-and-neck-cancers-march-an-updated/)
- [UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening](https://scholariq.org/papers/uk-lung-cancer-rct-pilot-screening-trial-baseline-findings-from-the-screening/)
- [Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials](https://scholariq.org/papers/neoadjuvant-chemotherapy-versus-debulking-surgery-in-advanced-tubo-ovarian/)

## Researcher topics

- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Meta-analysis and systematic reviews](https://scholariq.org/topics/meta-analysis-and-systematic-reviews/)

## Researcher university

- [MRC Clinical Trials Unit at UCL](https://scholariq.org/institutions/mrc-clinical-trials-unit-at-ucl/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.